Mechanisms of tolerance induced via mixed chimerism

Frontiers in Bioscience

Volumn 12, Issue 8, 2007, Pages 2922-2934

  Sykes, Megan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti CD154; Costimulatory blockade; Mixed chimerism; Review; Tolerance

Indexed keywords

ANIMAL; BONE MARROW TRANSPLANTATION; CHIMERA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; REVIEW;

ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERA; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE;

EID: 34347218592     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2282     Document Type: Article

References (142)

1. R. D. Owen: Immunogenetic consequences of vascular anastomoses between bovine twins. Science, 102, 400-401 (1945)
2. D. Anderson, R. E. Billingham, G. H. Lampkin, and P. B. Medawar: The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity, 5, 379-397 (1951)
3. R. E. Billingham, G. H. Lampkin, P. B. Medawar, and H. Ll. Williams: Tolerance to homografts, twin diagnosis, and the freemartin condition in cattle. Heredity, 6, 201-212 (1952)
4. R. E. Billingham, L. Brent, and P. B. Medawar: "Actively acquired tolerance" of foreign cells. Nature, 172, 603-606 (1953)
5. J. M. Main and R. T. Prehn: Succesful skin homografts after the administration of high dosage X radiation and homologous bone marrow. Journal of the National Cancer Institute, 15, 1023 (1955)
6. R. A. Clift and R. Storb: Histoincompatible bone marrow transplants in humans. Annual Reviews of Immunology, 5, 43-64 (1987)
7. C. Anasetti, D. Amos, P. G. Beatty, F. R. Appelbaum, W. Bensinger, C. D. Buckner, R. Clift, C. Doney, P. J. Martin, E. Mickelson, B. Nisperos, J. O'Quigley, R. Ramberg, J. E. Sanders, P. Stewart, R. Storb, K. M. Sullivan, R. P. Witherspoon, E. D. Thomas, and J. A. Hansen: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New England Journal of Medicine, 320, 197-204 (1989) (Pubitemid 19034144)
8. N. A. Kernan, N. Flomenberg, B. Dupont, and R. J. O'Reilly: Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation, 43, 842-847 (1987)
9. Y. Sharabi and D. H. Sachs: Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. Journal of Experimental Medicine, 169, 493-502 (1989) (Pubitemid 19050646)
10. A. Singer, K. S. Hathcock, and R. J. Hodes: Self recognition in allogeneic radiation chimeras. A radiation resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. Journal of Experimental Medicine, 153, 1286-1301 (1981) (Pubitemid 11107595)
11. R. M. Zinkernagel, G. N. Callahan, A. Althage, S. Cooper, P. A. Klein, and J. Klein: On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? Journal of Experimental Medicine, 147, 882-896 (1978)
12. R. M. Zinkernagel, A. Althage, G. Callahan, and R. M. Welsh Jr.: On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. Journal of Immunology, 124, 2356-2365 (1980) (Pubitemid 10113332)
13. S. T. Ildstad, S. M. Wren, J. A. Bluestone, S. A. Barbieri, and D. H. Sachs: Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. Journal of Experimental Medicine, 162, 231-244 (1985) (Pubitemid 15029899)
14. E. Ruedi, M. Sykes, S. T. Ildstad, C. H. Chester, A. Althage, H. Hengartner, D. H. Sachs, and R. M. Zinkernagel: Antiviral T cell competence and restriction specificty of mixed allogeneic (P1+P2→P1) irradiation chimeras. Cellular Immunology, 121, 185-195 (1989) (Pubitemid 19160196)
15. S. Slavin, S. Strober, Z. Fuks, and H. S. Kaplan: Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: longterm survival of allogeneic bone marrow and skin grafts. Journal of Experimental Medicine, 146, 34 (1977)
16. S. Slavin, Z. Fuks, H. S. Kaplan, and S. Strober: Transplantation of allogeneic bone marrow without graftversus-host disease using total lymphoid irradiation. Journal of Experimental Medicine, 147, 963-972 (1978) (Pubitemid 8318066)
17. S. Slavin, B. Reitz, C. P. Bieber, H. S. Kaplan, and S. Strober: Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. Journal of Experimental Medicine, 147, 700-707 (1978) (Pubitemid 8303484)
18. D. A. Vallera, C. C. B. Soderling, G. J. Carlson, and J. H. Kersey: Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in toltal lymphoid irradiation-conditioned recipients. Transplantation, 33, 243-248 (1982) (Pubitemid 12192430)
19. S. T. Ildstad and D. H. Sachs: Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature, 307(5947), 168-170 (1984) (Pubitemid 14132903)
20. Y. Tomita, D. H. Sachs, and M. Sykes: Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood, 83, 939-948 (1994) (Pubitemid 24058543)
21. Y. Sharabi, V. S. Abraham, M. Sykes, and D. H. Sachs: Mixed allogeneic chimeras prepared by a nonmyeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplantation, 9, 191-197 (1992)
22. Y. Tomita, D. H. Sachs, A. Khan, and M. Sykes: Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation, 61, 469-477 (1996)
23. Y. Tomita, A. Khan, and M. Sykes: Mechanism by which additional monoclonal antibody injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation, 61, 477-485 (1996)
24. T. Wekerle, M. H. Sayegh, H. Ito, J. Hill, A. Chandraker, D. A. Pearson, K. G. Swenson, G. Zhao, and M. Sykes: Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation, 68, 1348-1355 (1999)
25. H. Mayumi and R. A. Good: Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. Journal of Experimental Medicine, 169, 213-238 (1989) (Pubitemid 19035553)
26. K. Nomoto, K. Yung-Yun, K. Omoto, M. Umesue, Y. Murakami, and G. Matsuzaki: Tolerance induction in a fully allogeneic combination using anti-T cell receptor-ab monoclonal antibody, low dose irradiation, and donor bone marrow transfusion. Transplantation, 59, 395-401 (1995)
27. Y. L. Colson, S. M. Wren, M. J. Schuchert, K. D. Patrene, P. C. Johnson, S. S. Boggs, and S. T. Ildstad: A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. Journal of Immunology, 155, 4179-4188 (1995)
28. A. De Vries-van der Zwan, A. C. Besseling, F. Kievits, E. Van Twuyver, and L. P. De Waal: Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance. Transplantation, 58, 610-617 (1994) (Pubitemid 24289854)
29. A. De Vries-van der Zwan, A. C. Besseling, L. P. De Waal, and C. J. P. Boog: Specific tolerance induction and transplantation: a single-day protocol. Blood, 89, 2596-2601 (1997) (Pubitemid 27143310)
30. U. Koch and R. Korngold: A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers. Blood, 89, 2880-2890 (1997) (Pubitemid 27172575)
31. A. De Vries-van der Zwan, M. A. van der Pol, A. C. Besseling, L. P. De Waal, and C. J. P. Boog: Haematopoietic stem cells can induce specific skin graft acceptance across a full MHC barrier. Bone Marrow Transplantation, 22, 91-98 (1998) (Pubitemid 28330542)
32. C. L. Mackall, T. A. Fleisher, M. R. Brown, M. P. Andrich, C. C. Chen, I. M. Feuerstein, M. E. Horowitz, I. T. Magrath, A. T. Shad, S. M. Steinberg, L. H. Wexler, and R. E. Gress: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New England Journal of Medicine, 332, 143-149 (1995)
33. B. F. Haynes, M. L. Markert, G. D. Sempowski, D. D. Patel, and L. P. Hale: The role of the thymus in immune reconstiutution in aging, bone marrow transplantion, and HIV-1 infection. Annual Reviews of Immunology, 18, 529-560 (2000) (Pubitemid 30365390)
34. F. T. Hakim, S. A. Memon, R. Cepeda, E. C. Jones, C. K. Chow, C. Kasten-Sportes, J. Odom, B. A. Vance, B. L. Christensen, C. L. Mackall, and R. E. Gress: Agedependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest, 115, 930-939 (2005) (Pubitemid 40489397)
35. T. Wekerle, M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M. Sykes: Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. Journal of Experimental Medicine, 187, 2037-2044 (1998) (Pubitemid 28285573)
36. A. B. Adams, M. M. Durham, L. Kean, N. Shirasugi, J. Ha, M. A. Williams, P. A. Rees, M. C. Cheung, S. Mittelstaedt, A. W. Bingaman, D. R. Archer, T. C. Pearson, E. K. Waller, and C. P. Larsen: Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. Journal of Immunology, 167, 1103-1111 (2001) (Pubitemid 32660871)
37. M. M. Durham, A. W. Bingaman, A. B. Adams, J. Ha, S. Y. Waitze, T. C. Pearson, and C. P. Larsen: Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. Journal of Immunology, 165, 1-4 (2000) (Pubitemid 30429481)
38. N. Shirasugi, A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen: Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism-and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J Immunol, 169, 2677-2684 (2002) (Pubitemid 34921016)
39. P. A. Taylor, C. J. Lees, J. M. Wilson, M. J. Erhardt, M. T. Campbell, R. J. Noelle, and B. R. Blazar: Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood, 100, 3400-3407 (2002) (Pubitemid 35217093)
40. P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar: Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions. Blood, 98, 467-474 (2001)
41. D. A. Hale, R. Gottschalk, A. Umemura, T. Maki, and A. P. Monaco: Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation, 69, 1242-1251 (2000) (Pubitemid 30238707)
42. J. F. Lambert, G. A. Colvin, S. Zhong, H. Wang, L. D'Hondt, M. Abedi, A. E. Frimberger, F. M. Stewart, and P. J. Quesenberry: H2-mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation. Br. J Haematol., 119, 155-163 (2002) (Pubitemid 35176515)
43. L. A. Turka, P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Wei, M. L. Gibson, X. Zhen, S. Myrdal, D. Gordon, T. Bailey, S. F. Bolling, and C. B. Thompson: T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proceedings of the National Academy of Science USA, 89, 11102 (1992)
44. M. H. Sayegh, E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. Journal of Experimental Medicine, 181, 1869-1874 (1995)
45. D. C. Parker, D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini: Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proceedings of the National Academy of Science USA, 92, 9560-9564 (1995)
46. M. H. Sayegh, X.-G. Zheng, C. Magee, W. W. Hancock, and L. A. Turka: Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Transplantation, 64, 1646-1650 (1997) (Pubitemid 28041694)
47. T. G. Markees, N. E. Phillips, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner, and A. A. Rossini: Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation, 64, 329-335 (1997) (Pubitemid 27332681)
48. T. G. Markees, N. E. Phillips, E. J. Gordon, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner, and A. A. Rossini: Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, Interferon-g, and CTLA4. Journal of Clinical Investigation, 101, 2446-2455 (1998) (Pubitemid 28270439)
49. T. A. Judge, Z. Wu, X.-G. Zheng, A. H. Sharpe, M. H. Sayegh, and L. A. Turka: The role of CD80, CD86 and CTLA4 in alloimmune responses and the induction of longterm allograft survival. Journal of Immunology, 162, 1947-1951 (1999) (Pubitemid 29288810)
50. B. Nikolic, A. Khan, and M. Sykes: Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance. Biol. Blood Marrow Transplant., 7, 144-153 (2001) (Pubitemid 32294213)
51. A. B. Adams, M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherry, T. Onami, J. G. Lanier, K. E. Kokko, T. C. Pearson, R. Ahmed, and C. P. Larsen: Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin. Invest, 111, 1887-1895 (2003) (Pubitemid 38057733)
52. J. H. Chace, J. S. Cowdery, and E. H. Field: Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. Journal of Immunology, 152, 405-412 (1994) (Pubitemid 24072943)
53. J. P. Pearl, J. Parris, D. A. Hale, S. C. Hoffmann, W. B. Bernstein, K. L. McCoy, S. J. Swanson, R. B. Mannon, M. Roederer, and A. D. Kirk: Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant, 5, 465-474 (2005) (Pubitemid 40313337)
54. Y. Chen, P. S. Heeger, and A. Valujskikh: In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol, 172, 5456-5466 (2004) (Pubitemid 38542046)
55. R. Kiessling, P. S. Hochman, O. Haller, G. M. Shearer, H. Wigzell, and G. Cudkowicz: Evidence for a similar or common mechanism for natural killer activity and resistance to hemopoietic grafts. Eur. J. Immunol., 7, 655-663 (1977) (Pubitemid 8200519)
56. W. J. Murphy, V. Kumar, and M. Bennett: Rejection of bone marrow allografts by mice with severe combined immune deficiency (scid). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. Journal of Experimental Medicine, 165, 1212-1217 (1987) (Pubitemid 17064517)
57. L. S. Kean, K. Hamby, B. Koehn, E. Lee, S. Coley, L. Stempora, A. B. Adams, E. Heiss, T. C. Pearson, and C. P. Larsen: NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant, 6, 292-304 (2006) (Pubitemid 43382164)
58. L. A. Lee, J. J. Sergio, and M. Sykes: Natural killer cells weakly resist engraftment of allogeneic long-term multilineage-repopulating hematopoietic stem cells. Transplantation, 61, 125-132 (1996) (Pubitemid 26033389)
59. J. O. Manilay, G. L. Waneck, and M. Sykes: Altered expression of Ly-49 receptors on natural killer cells developing in mixed allogeneic bone marrow chimeras. Int. Immunol., 10, 1943-1955 (1998) (Pubitemid 28566057)
60. Y. Zhao, H. Ohdan, J. O. Manilay, and M. Sykes: NK cell tolerance in mixed allogeneic chimeras. Journal of Immunology, 170, 5398-5405 (2003) (Pubitemid 36617825)
61. I. Aksentijevich, D. H. Sachs, and M. Sykes: Natural antibodies can inhibit bone marrow engraftment in the rat->mouse species combination. Journal of Immunology, 147, 4140-4146 (1991)
62. H. Ohdan, K. G. Swenson, H. Kitamura, Y.-G. Yang, and M. Sykes: Tolerization of Gala1, 3Gal-reactive B cells in presensitized a1, 3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation, 8, 227-238 (2002) (Pubitemid 33020981)
63. R. J. Benjamin, J. M. Connors, S. McGurk, W. H. Churchill, and J. H. Antin: Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol. Blood Marrow Transplant., 4, 151-156 (1998) (Pubitemid 128538806)
64. J. P. Gmür, J. Burger, A. Schaffner, K. Neftel, O. Oelz, D. Frey, and M. Metaxas: Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood, 75, 290-295 (1990) (Pubitemid 20031523)
65. J. D. Seebach, G. Stussi, J. R. Passweg, F. R. Loberiza, Jr., J. L. Gajewski, A. Keating, M. Goerner, P. A. Rowlings, P. Tiberghien, G. J. Elfenbein, R. P. Gale, J. J. Van Rood, V. Reddy, E. Gluckman, B. J. Bolwell, T. R. Klumpp, M. M. Horowitz, O. Ringden, and A. J. Barrett: ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited. Biol Blood Marrow Transplant, 11, 1006-1013 (2005) (Pubitemid 41754719)
66. I. Aksentijevich, D. H. Sachs, Y. Sharabi, T. M. I. Sundt, and M. Sykes: Humoral tolerance in mixed xenogeneic chimeras prepared by a non-myeloablative conditioning regimen. Transplant. Proc., 23, 880-882 (1991)
67. H. Ohdan, Y.-G. Yang, A. Shimizu, K. G. Swenson, and M. Sykes: Mixed bone marrow chimerism induced without lethal conditioning prevents T cell and anti-Gala1, 3Gal antibody-mediated heart graft rejection. Journal of Clinical Investigation, 104, 281-290 (1999)
68. H. Ohdan, Y.-G. Yang, K. G. Swenson, H. Kitamura, and M. Sykes: T cell and B cell tolerance to gala1, 3galexpressing heart xenografts is achieved in a1, 3-galactosyltransferase-deficient mice by non-myeloablative induction of mixed chimerism. Transplantation, 71, 1532-1542 (2001) (Pubitemid 32574151)
69. H. Ito, Y. Takeuchi, J. Shaffer, and M. Sykes: Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and non-irradiated sites. Blood, 103, 1949-1954 (2003) (Pubitemid 38268997)
70. F. M. Stewart, R. B. Crittenden, P. A. Lowry, S. Pearson-White, and P. J. Quesenberry: Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood, 81, 2566-2571 (1993) (Pubitemid 23147558)
71. H. S. Ramshaw, S. S. Rao, R. B. Crittenden, S. O. Peters, H.-U. Weier, and P. J. Quesenberry: Engraftment of bone marrow cells into normal unprepared hosts: effects of 5-fluorouracil and cell cycle status. Blood, 86, 924-929 (1995)
72. H. S. Ramshaw, R. B. Crittenden, M. Dooner, S. O. Peters, S. S. Rao, and P. J. Quesenberry: High levels of engraftment with a single infusion of bone marrow cells into normal unprepared mice. Biol. Blood Marrow Transplant., 1, 74-80 (1995)
73. S. S. Rao, S. O. Peters, R. B. Crittenden, F. M. Stewart, H. S. Ramshaw, and P. J. Quesenberry: Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment. Experimental Hematology, 25, 114-121 (1997) (Pubitemid 27101325)
74. M. Sykes, G. L. Szot, K. Swenson, D. A. Pearson, and T. Wekerle: Separate regulation of peripheral hematopoietic and thymic engraftment. Experimental Hematology, 26, 457-465 (1998) (Pubitemid 28247311)
75. M. Sykes, G. L. Szot, K. Swenson, and D. A. Pearson: Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nature Medicine, 3, 783-787 (1997) (Pubitemid 27298725)
76. T. Wekerle, J. Kurtz, H. Ito, J. V. Ronquillo, V. Dong, G. Zhao, J. Shaffer, M. H. Sayegh, and M. Sykes: Allogeneic bone marrow translantation with costimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Medicine, 6, 464-469 (2000) (Pubitemid 30208167)
77. J. W. Kappler, N. Roehm, and P. Marrack: T cell tolerance by clonal elimination in the thymus. Cell, 49, 273-280 (1987)
78. F. Ramsdell, T. Lantz, and B. J. Fowlkes: A nondeletional mechanism of thymic self tolerance. Science, 246, 1038-1041 (1989) (Pubitemid 20010528)
79. T. Brocker, M. Riedinger, and K. Karjalainen: Targeted expression of major histocompatibiity complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. Journal of Experimental Medicine, 185, 541-550 (1997) (Pubitemid 27078372)
80. M. Inaba, K. Inaba, M. Hosono, T. Kumamoto, T. Ishida, S. Muramatsu, T. Masuda, and S. Ikehara: Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. Journal of Experimental Medicine, 173, 549-559 (1991)
81. Y. Tomita, A. Khan, and M. Sykes: Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantion in mice conditioned with a non-myeloablative regimen. Journal of Immunology, 153, 1087-1098 (1994) (Pubitemid 24228500)
82. J. O. Manilay, D. A. Pearson, J. J. Sergio, K. G. Swenson, and M. Sykes: Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation, 66, 96-102 (1998) (Pubitemid 28341174)
83. A. Khan, Y. Tomita, and M. Sykes: Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation, 62, 380-387 (1996) (Pubitemid 26277346)
84. F. Ramsdell and B. J. Fowlkes: Maintenance of in vivo tolerance by persistence of antigen. Science, 257, 1130-1134 (1992)
85. B. Rocha, C. Tanchot, and H. Von Boehmer: Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. Journal of Experimental Medicine, 177, 1517-1521 (1993) (Pubitemid 23117145)
86. T. Wekerle, J. Kurtz, S. Bigenzahn, Y. Takeuchi, and M. Sykes: Mechanisms of transplant tolerance induction with costimulatory blockade. Curr. Opin. Immunol., 14, 592-600 (2002)
87. K. Honey, S. P. Cobbold, and H. Waldmann: CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. Journal of Immunology, 163, 4805-4810 (1999) (Pubitemid 29501243)
88. L. Graca, K. Honey, E. Adams, S. P. Cobbold, and H. Waldmann: Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. Journal of Immunology, 165, 4783-4786 (2000)
89. B. T. Konieczny, Z. Dai, E. T. Elwood, S. Saleem, P. S. Linsley, F. K. Baddoura, C. P. Larsen, T. C. Pearson, and F. G. Lakkis: IFN-g is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. Journal of Immunology, 160, 2059-2064 (1998) (Pubitemid 28119882)
90. Z. Dai, B. T. Konieczny, F. K. Baddoura, and F. G. Lakkis: Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. Journal of Immunology, 161, 1659-1663 (1998) (Pubitemid 28387581)
91. A. Chandraker, M. E. Russell, T. Glysing-Jensen, T. A. Willett, and M. H. Sayegh: T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen. Transplantation, 63, 1053-1058 (1997) (Pubitemid 27190966)
92. Y. Li, X. X. Zheng, X. C. Li, M. S. Zand, and T. B. Strom: Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation, 66, 1387-1388 (1998) (Pubitemid 28551024)
93. M. Sho, H. Harada, D. M. Rothstein, and M. H. Sayegh: CD45RB-targeting strategies for promoting longterm allograft survival and preventingchronic allograft vasculopathy. Transplantation, 75, 1142-1146 (2003) (Pubitemid 36513011)
94. K. Kishimoto, S. Sandner, J. Imitola, M. Sho, Y. Li, P. B. Langmuir, D. M. Rothstein, T. B. Strom, L. A. Turka, and M. H. Sayegh: Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest, 109, 1471-1479 (2002) (Pubitemid 34596173)
95. X. C. Li, A. D. Wells, T. B. Strom, and L. A. Turka: The role of T cell apoptosis in transplantation tolerance. Curr. Opin. Immunol., 12, 522-527 (2000)
96. A. D. Wells, X. C. Li, Y. Li, M. Walsh, X. XC. Zheng, Z. Wu, G. Nunez, A. Tang, M. Sayegh, W. W. Hancock, T. B. Strom, and L. A. Turka: Requirement for T cell apoptosis in the induction of peripheral transplantation tolerance. Nature Medicine, 5, 1303-1312 (1999)
97. J. Kurtz, J. Shaffer, N. Anosova, G. Benichou, and M. Sykes: Mechanisms of early peripheral CD4 T cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: Evidence for anergy and deletion, but not regulatory cells. Blood, 103, 4336-4343 (2004) (Pubitemid 38685382)
98. T. Fehr, Y. Takeuchi, J. Kurtz, and M. Sykes: Rapid peripheral deletion of donor-reactive CD8 T cells permits mixed allogeneic chimerism and tolerance induction in recipients of anti-CD40L and allogeneic BMT: Short-term regulation by CD4 cells. Eur J Immunol, 35, 2679-2690 (2005) (Pubitemid 41404051)
99. H. Ito, J. Kurtz, J. Shaffer, and M. Sykes: CD4 T cellmediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40L interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. Journal of Immunology, 166, 2981 (2001)
100. Z. Guo, J. Wang, Y. Dong, A. B. Adams, N. Shirasugi, O. Kim, J. Hart, M. Newton-West, T. C. Pearson, C. P. Larsen, and K. A. Newell: Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant, 3, 1091-1098 (2003) (Pubitemid 37064548)
101. J. Kurtz, H. Ito, T. Wekerle, J. Shaffer, and M. Sykes: Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: Lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells. Am. J. Transplant., 1, 339-349 (2001) (Pubitemid 33681698)
102. N. J. Monk, R. E. Hargreaves, J. E. Marsh, C. A. Farrar, S. H. Sacks, M. Millrain, E. Simpson, J. Dyson, and S. Jurcevic: Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med, 9, 1275-1280 (2003) (Pubitemid 37279850)
103. H. Waldmann: The new immunosuppression: just kill the T cell. Nat Med, 9, 1259-1260 (2003) (Pubitemid 37279844)
104. J. Kaye, M.-L. Hsu, M.-E. Sauron, S. C. Jameson, N. R. J. Gasgiogne, and S. M. Hedrick: Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature, 341, 746 (1989)
105. J. Kaye, N. J. Vasquez, and S. M. Hedrick: Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. Journal of Immunology, 148, 3342-3353 (1992)
106. P. Fink, L. Matis, D. McElligot, M. Bookman, and S. Hedrick: Correlations between T-cell specificity and the structure of the antigen receptor. Nature, 321, 219 (1986)
107. N. J. Vasquez, J. Kaye, and S. M. Hedrick: In vivo and in vitro clonal deletion of double-positive thymocytes. Journal of Experimental Medicine, 175, 1307-1316 (1992)
108. J. Kurtz, A. Lie, M. Griffith, S. Eysaman, J. Shaffer, N. Anosova, L. Turka, G. Benichou, and M. Sykes: Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4+ T cells via BMT and anti-CD40L. Am. J. Transplant., 3, 804-816 (2003) (Pubitemid 36827902)
109. T. Wekerle, J. Kurtz, M. H. Sayegh, H. Ito, A. D. Wells, S. Bensinger, J. Shaffer, L. A. Turka, and M. Sykes: Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activationinduced cell death and passive cell death. Journal of Immunology, 166, 2311-2316 (2001) (Pubitemid 32173463)
110. Y. Rafaeli, L. Van Parijs, S. I. Alexander, and A. K. Abbas: Interferon gamma Is required for activation-induced death of T lymphocytes. J Exp Med, 196, 999-1005 (2002)
111. M. A. Curotto de Lafaille and J. J. Lafaille: CD4 (+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol, 14, 771-778 (2002) (Pubitemid 35292425)
112. M. Murakami, A. Sakamoto, J. Bender, J. Kappler, and P. Marrack: CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci U S A, 99, 8832-8837 (2002) (Pubitemid 34693644)
113. Q. Tang, K. J. Henriksen, E. K. Boden, A. J. Tooley, J. Ye, S. K. Subudhi, X. X. Zheng, T. B. Strom, and J. A. Bluestone: Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol, 171, 3348-3352 (2003) (Pubitemid 37254533)
114. S. J. Bensinger, P. T. Walsh, J. Zhang, M. Carroll, R. Parsons, J. C. Rathmell, C. B. Thompson, M. A. Burchill, M. A. Farrar, and L. A. Turka: Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol, 172, 5287-5296 (2004) (Pubitemid 38542026)
115. A. M. Thornton, E. E. Donovan, C. A. Piccirillo, and E. M. Shevach: Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol, 172, 6519-6523 (2004) (Pubitemid 38669083)
116. R. S. Gruchalla, P. G. Strome, and J. W. Streilein: Analysis of neonatally induced tolerance of H-2 alloantigens. III. Ease of abolition of tolerance of class I, but not class II, antigens with infusions of syngeneic, immunocompetent cells. Transplantation, 36, 318-323 (1983) (Pubitemid 13002683)
117. H. Ramseier: Immunization against abolition of transplantation tolerance. Eur. J. Immunol., 3, 156-164 (1973)
118. R. E. Billingham, L. Brent, and P. B. Medawar: Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Philos. Trans. Royal Society, 239(Ser. B), 44 (1955)
119. C. Domenig, A. Sanchez-Fueyo, J. Kurtz, S. P. Alexopoulos, C. Mariat, M. Sykes, T. B. Strom, and X. X. Zheng: Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J Immunol, 175, 51-60 (2005) (Pubitemid 40884301)
120. R. Scully, S. Qin, S. Cobbold, and H. Waldmann: Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur. J. Immunol., 24, 2383-2392 (1994) (Pubitemid 24303082)
121. H. Quill: Anergy as a mechanism of peripheral T cell tolerance. Journal of Immunology, 156, 1325-1327 (1996) (Pubitemid 26065837)
122. A. D. Wells, M. C. Walsh, J. A. Bluestone, and L. A. Turka: Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest, 108, 895-903 (2001)
123. N. N. Iwakoshi, J. P. Mordes, T. G. Markees, N. E. Phillips, A. A. Rossini, and D. L. Greiner: Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. Journal of Immunology, 164, 512-521 (2000) (Pubitemid 30013028)
124. N. N. Iwakoshi, T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini: Skin allograft maintenance in a new synchimeric model system of tolerance. Journal of Immunology, 167, 6623-6630 (2001) (Pubitemid 33081600)
125. Y. Takeuchi, H. Ito, J. Kurtz, T. Wekerle, L. Ho, and M. Sykes: Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L. Am J Transplant, 4, 31-40 (2004) (Pubitemid 38155487)
126. X.-X. Zheng, T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom: CTLA4 signals are required to optimally induce allograft tolerance with combined donorspecific transfusion and anti-CD154 monoclonal antibody treatment. Journal of Immunology, 162, 4983-4990 (1999) (Pubitemid 29314906)
127. A. O'Garra and P. Vieira: Regulatory T cells and mechanisms of immune system control. Nat Med, 10, 801-805 (2004) (Pubitemid 39070850)
128. S. Bigenzahn, P. Blaha, Z. Koporc, I. Pree, E. Selzer, H. Bergmeister, F. Wrba, C. Heusser, K. Wagner, F. Muehlbacher, and T. Wekerle: The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant, 5, 1237-1247 (2005) (Pubitemid 40839411)
129. G. Schonrich, G. Strauss, K.-P. Muller, L. Dustin, D. Y. Loh, N. Auphan, A.-M. Schmitt-Verhulst, B. Arnold, and G. J. Hammerling: Distinct requirements of positive and negative selection for selecting cell type and CD8 interaction. Journal of Immunology, 151, 4098-4105 (1993) (Pubitemid 23298742)
130. F. Bemelman, K. Honey, E. Adams, S. Cobbold, and H. Waldmann: Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. Journal of Immunology, 160, 2645-2648 (1998) (Pubitemid 28136714)
131. I. R. Lemischka, D. H. Raulet, and R. C. Mulligan: Developmental potential and dynamic behavior of hematopoietic stem cells. Cell, 45, 917-927 (1986) (Pubitemid 16083695)
132. T. Kawai, A. B. Cosimi, R. B. COLVIN, J. Powelson, J. Eason, T. Kozlowski, M. Sykes, R. Monroy, M. Tanaka, and D. H. Sachs: Mixed allogeneic chimerism and renal allograft tolerance in cynomologous monkeys. Transplantation, 59, 256-262 (1995)
133. Fudaba, Y., T. R. Spitzer, J. Shaffer, T. Kawai, T. Fehr, F. Delmonico, F. Preffer, N. Tolkoff-Rubin, B. Dey, S. Saidman, A. Kraus, T. Bonnefoix, S. MCafee, K. Power, K. Kattleman, R. B. COLVIN, D. H. Sachs, A. B. Cosimi, & M. Sykes: Myeloma responses and tolerance following combined kidney and non-myeloablative marrow transplantation: in vivo and in vitro analyses. (2006) Ref Type: In Press
134. K. Hayamizu, F. Lan, P. Huie, R. K. Sibley, and S. Strober: Comparison of chimeric and non-chimeric tolerance using posttransplant total lymphiod irradiation. Cytokine expression and chronic rejection. Transplantation, 68, 1036-1044 (1999) (Pubitemid 29489332)
135. T. R. Spitzer, F. Delmonico, N. Tolkoff-Rubin, S. MCafee, R. Sackstein, S. Saidman, C. Colby, M. Sykes, D. H. Sachs, and A. B. Cosimi: Combined HLA-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation, 68, 480-484 (1999) (Pubitemid 29416620)
136. L. H. Buhler, T. R. Spitzer, M. Sykes, D. H. Sachs, F. L. Delmonico, N. Rubin-Tolkoff, S. L. Saidman, R. Sackstein, S. MCafee, B. Dey, C. Colby, and A. B. Cosimi: Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation, 74, 1405-1409 (2002)
137. T. Fehr and M. Sykes: Tolerance induction in clinical transplantation. Transpl Immunol, 13, 117-130 (2004) (Pubitemid 39222026)
138. T. Kawai, D. Andrews, R. B. COLVIN, D. H. Sachs, and A. B. Cosimi: Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand [letter]. Nat. Med., 6, 114 (2000) (Pubitemid 30082329)
139. I. Koyama, T. Kawai, D. Andrews, S. Boskovic, O. Nadazdin, S. L. Wee, H. Sogawa, D. L. Wu, R. N. Smith, R. B. COLVIN, D. H. Sachs, and A. B. Cosimi: Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation, 77, 460-462 (2004) (Pubitemid 38209752)
140. J. L. Ferrant, C. D. Benjamin, A. H. Cutler, S. L. Kalled, Y. M. Hsu, E. A. Garber, D. M. Hess, R. I. Shapiro, N. S. Kenyon, D. M. Harlan, A. D. Kirk, L. C. Burkly, and F. R. Taylor: The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. Int. Immunol, 16, 1583-1594 (2004) (Pubitemid 39480777)
141. T. Kanmaz, J. J. Fechner, Jr., J. Torrealba, H. T. Kim, Y. Dong, T. D. Oberley, J. M. Schultz, D. D. Bloom, M. Katayama, W. Dar, J. Markovits, W. Schuler, H. Hu, M. M. Hamawy, and S. J. Knechtle: Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation, 77, 914-920 (2004) (Pubitemid 38436834)
142. W. Schuler, M. Bigaud, V. Brinkmann, F. Di Padova, S. Geisse, H. Gram, V. Hungerford, B. Kleuser, C. Kristofic, K. Menninger, R. Tees, G. Wieczorek, C. Wilt, C. Wioland, and M. Zurini: Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation. Transplantation, 77, 717-726 (2004) (Pubitemid 38366978)